Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
NCT03298243

Use of Sensory Substitution to Improve Arm Control After Stroke

Led by Marquette University · Updated on 2025-09-29

30

Participants Needed

1

Research Sites

149 weeks

Total Duration

On this page

Sponsors

M

Marquette University

Lead Sponsor

M

Medical College of Wisconsin

Collaborating Sponsor

AI-Summary

What this Trial Is About

Supplementing or augmenting sensory information to those who have lost proprioception after stroke could help improve functional control of the arm. Thirty subjects will be recruited to a single site to evaluate the ability of supplemental kinesthetic feedback (a form of vibrotactile stimulation) to improve motor function. Participants will be tested in performing reaching movements as well as more functional tasks such as simulated drinking from a glass

CONDITIONS

Official Title

Use of Sensory Substitution to Improve Arm Control After Stroke

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Stroke survivors who can perform stabilization and grip modulation tasks
  • Had a single ischemic or hemorrhagic stroke of the middle cerebral artery in the chronic recovery phase (> 6 months post-stroke)
  • Ability to give informed consent and follow two-stage instructions
  • Mild-to-moderate motor impairment of the affected arm, with a Fugl-Meyer upper extremity score between 28 and 50 inclusive
  • Proprioceptive deficit at the elbow of the more involved arm
  • Preserved tactile sensation in the unaffected arm and/or thigh
  • Minimal active wrist extension of 5 degrees or more
Not Eligible

You will not qualify if you...

  • Inability to give informed consent or follow two-stage instructions
  • Bleeding disorders
  • Fixed contractures or history of tendon transfer in the affected limb
  • Diagnosis of myasthenia gravis, amyotrophic lateral sclerosis, or other diseases affecting neuromuscular function
  • Current use or influence of aminoglycoside antibiotics, curare-like agents, or other neuromuscular interfering drugs
  • History of epilepsy
  • Psychiatric co-morbidities such as schizophrenia
  • Malignant or benign intra-axial brain tumors
  • Concurrent illness limiting ability to comply with study requirements
  • Cardiac pacemaker, arrhythmia, or significant cardiovascular or respiratory problems
  • Profound muscle atrophy or excessive weakness in target testing areas
  • Systemic infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Marquette University

Milwaukee, Wisconsin, United States, 53233

Actively Recruiting

Loading map...

Research Team

R

Robert A Scheidt, PhD

CONTACT

K

Kimberly D Bassindale, DPT

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here